EX-23.1 6 lxeo-ex23_1.htm EX-23.1 EX-23.1


Exhibit 23.1

 

img238985936_0.jpg 

 

 

KPMG LLP

 

345 Park Avenue

 

New York, NY 10154-0102

Consent of Independent Registered Public Accounting Firm

We consent to the use of our audit report dated March 11, 2024, with respect to the consolidated financial statements of Lexeo Therapeutics, Inc., included herein.

/s/ KPMG LLP

New York, New York

March 11, 2024

KPMG LLP, a Delaware limited liability partnership and a member firm of

the KPMG global organization of independent member firms affiliated with

KPMG International Limited, a private English company limited by guarantee.

 

1